SPDR S&P Pharmaceuticals ETF
XPH
XPH
72 hedge funds and large institutions have $287M invested in SPDR S&P Pharmaceuticals ETF in 2014 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 25 increasing their positions, 22 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
8.49% less ownership
Funds ownership: 72.41% → 63.93% (-8.5%)
Holders
72
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$18M | |
| 2 | +$15.8M | |
| 3 | +$9.89M | |
| 4 |
Morgan Stanley
New York
|
+$8.59M |
| 5 |
LPL Financial
San Diego,
California
|
+$5.59M |
Top Sellers
| 1 | -$40.2M | |
| 2 | -$9.73M | |
| 3 | -$6.66M | |
| 4 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$4.17M |
| 5 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
-$2.83M |